Clinical trials
Phase 3 trials in Austria with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Vienna | 12 |
| European Organisation for Research and Treatment of Cancer - EORTC | 7 |
| Medical University Innsbruck | 4 |
| European Paediatric Soft Tissue Sarcoma Study Group | 2 |
| Medical University of Graz | 2 |
| St. Anna Kinderkrebsforschung | 2 |
| American College of Radiology - Image Metrix | 1 |
| Antisoma Research | 1 |
| Boston Scientific Corporation | 1 |
| Broncus Technologies | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Colorectal Neoplasms | 2 |
| Macular Degeneration | 2 |
| Neoplasm Metastasis | 2 |
| Sarcoma | 2 |
| Uterine Cervical Neoplasms | 2 |
| Anemia, Refractory | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Atrial Fibrillation | 1 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.